Close Menu

NEW YORK (GenomeWeb) – Agilent Technologies and BioTek Instruments have partnered to develop an integrated product for cellular metabolic analysis and imaging.

Specifically, the companies will integrate Agilent's Seahorse XFe96/XFe24 Analyzers with BioTek's Cytation 1 Cell Imaging Multi-Mode Reader. The combined product will enable a standardized approach to compare XF data sets, improve assay workflow, embed images into WAVE software, and apply normalization values to Seahorse XF measurements.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.